Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer

Patients with metastatic triple-negative breast cancer (mTNBC) have poor outcomes. The Intensive Trial of Omics in Cancer (ITOMIC) sought to determine the feasibility and potential efficacy of informing treatment decisions through multiple biopsies of mTNBC deposits longitudinally over time, accompa...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Kimberly A., Mahen, Elisabeth, Konnick, Eric Quentin, Blau, Sibel, Dorschner, Michael O., Ramirez, Arturo B., Schmechel, Stephen C., Song, Chaozhong, Parulkar, Rahul, Parker, Stephanie, Senecal, Francis Mark, Pritchard, Colin C., Mecham, Brigham H., Szeto, Christopher, Spilman, Patricia, Zhu, Jingchun, Gadi, Vijayakrishna K., Ronen, Roy, Stilwell, Jackie, Kaldjian, Eric, Dutkowski, Janusz, Benz, Stephen Charles, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Blau, C. Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939922/
https://www.ncbi.nlm.nih.gov/pubmed/35294224
http://dx.doi.org/10.1200/PO.21.00280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939922/
https://www.ncbi.nlm.nih.gov/pubmed/35294224
http://dx.doi.org/10.1200/PO.21.00280

Ejemplares similares